MICROBOT MEDICAL INC. Cost of Revenue
MICROBOT MEDICAL INC. (MBOT) reported Cost of Revenue of $884.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-11
- MICROBOT MEDICAL INC. cost of revenue for the quarter ending 2026-06-30 was $884.00K.
- MICROBOT MEDICAL INC. cost of revenue for the quarter ending 2026-03-31 was $103.00K.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month |
|---|---|---|
| 2026-06-30 | $884.00K 10-Q · filed 2026-08-11 | $987.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $103.00K 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |